5-hydroxydecanoate has been researched along with Diabetic Nephropathies in 1 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, B | 1 |
Shi, YQ | 1 |
Zou, JJ | 1 |
Chen, XF | 1 |
Tang, W | 1 |
Ye, F | 1 |
Liu, ZM | 1 |
1 other study available for 5-hydroxydecanoate and Diabetic Nephropathies
Article | Year |
---|---|
High glucose stimulates cell proliferation and Collagen IV production in rat mesangial cells through inhibiting AMPK-K
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Proliferation; Cells, Cultu | 2017 |